Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation
| Autor: | Planagumà, A., Domènech, T., Pont, M., Calama, E., García-González, V., López, R., Aulí, M., López, M., Fonquerna, S., Ramos, I., de Alba, J., Nueda, A., Prats, N., Segarra, V., Miralpeix, M., Lehner, M.D. |
|---|---|
| Zdroj: | In Pulmonary Pharmacology & Therapeutics October 2015 34:37-45 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect